glp 1 medications mechanism of action GLP-1 Agonists - What is it? Evolution of GLP‐1 Receptor Agonists

ACT 2: Tirzepatide (Mounjaro & Zepbound) More Flexibility, Same Discipline Tirzepatide is a dual GIP/GLP-1 receptor agonist, making it pharmacologically distinct from semaglutide

December 15, 2025: Study About the Brain Benefits of Taking Trulicity Shows Modest Connection, Inconclusive Results An observational study explored whether taking Trulicity and other GLP-1s was associated with some brain benefits, like lower risks of epilepsy

Researchers should note that most indirect comparisons carry the limitations inherent to cross-trial analyses, including differences in baseline populations and trial design

Ultherapy: Uses ultrasound energy to lift and firm the skin on the face, neck, and dcolletage

Lower doses of semaglutide (0.1 and 0.3 mg/kg) reduced chow intake but not sucrose intake nor VTA dopamine activity in the task